Home › Ovarian Cancer › New Hampshire
Ovarian Cancer clinical trials in New Hampshire
4 studies for Ovarian Cancer are looking for participants at sites in New Hampshire.
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Dartmouth-Hitchcock Medical Center /ID# 274676, Lebanon
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Recruiting
Ages 35 to 50 · Women · Updated Aug 7, 2026 · NCT04251052Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
- Dartmouth Hitchcock, Lebanon
- Dartmouth-Hitchcock Manchester, Manchester
RecruitingPhase 2
Ages 18 and older · Women · Updated Jan 28, 2026 · NCT06815497From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.